Cargando…
SARS-CoV-2 as an Oncolytic Virus Following Reactivation of the Immune System: A Review
The effects SARS-CoV-2 inflicts on human physiology, especially in patients who developed COVID-19, can range from flu-like symptoms to death, and although many lives have been lost during the pandemic, others have faced the resolution of aggressive neoplasms that once proclaimed a poor prognosis fo...
Autores principales: | Bounassar-Filho, Joao P., Boeckler-Troncoso, Laura, Cajigas-Gonzalez, Jocelyne, Zavala-Cerna, Maria G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9916917/ https://www.ncbi.nlm.nih.gov/pubmed/36768649 http://dx.doi.org/10.3390/ijms24032326 |
Ejemplares similares
-
SARS-CoV-2 RBD protein enhances the oncolytic activity of the vesicular stomatitis virus
por: Alkayyal, Almohanad A., et al.
Publicado: (2023) -
Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV
por: Ou, Xiuyuan, et al.
Publicado: (2020) -
Electrochemical genosensor for the specific detection of SARS-CoV-2
por: Cajigas, Sebastian, et al.
Publicado: (2022) -
Oncolytic viruses for cancer immunotherapy
por: Hemminki, Otto, et al.
Publicado: (2020) -
Oncolytic Viruses and the Immune System: The Dynamic Duo
por: Lemos de Matos, Ana, et al.
Publicado: (2020)